EP 1030908 A1 20000830 - GENETICALLY-MODIFIED MYOGENIC PROGENITORS AND THEIR USE IN CELL AND GENE THERAPY
Title (en)
GENETICALLY-MODIFIED MYOGENIC PROGENITORS AND THEIR USE IN CELL AND GENE THERAPY
Title (de)
GENETISCH MODIFIZIERTE MYOGENE VORLÄUFER UND IHRE VERWENDUNG ZUR ZELL- UND GENTHERAPIE
Title (fr)
PROGENITEURS MYOGENES GENETIQUEMENT MODIFIES ET LEUR UTILISATION EN THERAPIE GENIQUE ET CELLULAIRE
Publication
Application
Priority
- EP 9807263 W 19981113
- IT MI972542 A 19971114
Abstract (en)
[origin: WO9925814A1] The present invention has as an object engineered myogenic progenitors derived from bone marrow, useful in muscular dystrophy gene therapy.
IPC 1-7
IPC 8 full level
A61K 35/28 (2006.01); A61P 21/04 (2006.01); C12N 5/06 (2006.01); C12N 5/0775 (2010.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); A61K 35/12 (2006.01); A61K 48/00 (2006.01)
CPC (source: EP)
A61P 21/04 (2017.12); C12N 5/0663 (2013.01); A61K 48/00 (2013.01); A61K 2035/124 (2013.01)
Citation (search report)
See references of WO 9925814A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9925814 A1 19990527; WO 9925814 B1 19990722; AU 1872599 A 19990607; CA 2310016 A1 19990527; EP 1030908 A1 20000830; IT 1296439 B1 19990625; IT MI972542 A1 19990514; JP 2001523448 A 20011127
DOCDB simple family (application)
EP 9807263 W 19981113; AU 1872599 A 19981113; CA 2310016 A 19981113; EP 98963450 A 19981113; IT MI972542 A 19971114; JP 2000521180 A 19981113